The impact of EGFR mutation and PD-L1 status on the efficacy of postoperative radiotherapy in stage III-pN2 NSCLC

Abstract Background The role of postoperative radiotherapy (PORT) for patients with completely resected stage III-pN2 non-small-cell lung cancer (NSCLC) remains controversial. PORT is not routinely recommended for patients with completely resected stage III-pN2 NSCLC. Therefore, identifying the popu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jinquan Yao, Yuxin Geng, Junhao Xu, Bingwen Zou, Feifei Teng
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-14255-0
Tags: Add Tag
No Tags, Be the first to tag this record!